Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global COPD and asthma devices market size reached US$ 40.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 57.09 Billion by 2027, exhibiting a growth rate (CAGR) of 5.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

  • Inhalers
    • Drug Powdered Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
    • Soft Mist Inhalers
  • Nebulizers
    • Compressor Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers
       

Breakup by Indication:

  • Asthma
  • COPD
     

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Indication, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global COPD and asthma devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global COPD and asthma devices market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global COPD and Asthma Devices Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Inhalers
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Drug Powdered Inhalers (DPIs)
           6.1.2.2 Metered Dose Inhalers (MDIs)
           6.1.2.3 Soft Mist Inhalers
        6.1.3 Market Forecast
    6.2    Nebulizers
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Compressor Nebulizers
           6.2.2.2 Ultrasonic Nebulizers
           6.2.2.3 Mesh Nebulizers
        6.2.3 Market Forecast
7    Market Breakup by Indication
    7.1    Asthma
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    COPD
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Retail Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hospitals
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Adherium Limited
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Aristopharma Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    AstraZeneca PLC
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Baxter International Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Boehringer Ingelheim International GmbH
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Cohero Health Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Koninklijke Philips N.V. 
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Omron Corporation
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Pari Respiratory Equipment Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Recipharm AB
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Verona Pharma plc
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2021
Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2021
Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2021
Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2021
Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
Table 7: Global: COPD and Asthma Devices Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4